Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils

Journal of Neurochemistry

Volumn 126, Issue 3, 2013, Pages 305-311

  Gu, Lei ^a   Guo, Zhefeng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

electron paramagnetic resonance; protein aggre gation; senile plaques; spin labeling

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; SPIN LABELING;

ELECTRON PARAMAGNETIC RESONANCE; PROTEIN AGGRE-GATION; SENILE PLAQUES; SPIN LABELING;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; PEPTIDE FRAGMENTS; SPIN LABELS;

EID: 84880572550     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12202     Document Type: Article

References (31)

1. Agopian A., and, Guo Z., (2012) Structural origin of polymorphism for Alzheimer's amyloid-β fibrils. Biochem. J. 447, 43-50.
2. Baker R. T., Catanzariti A. M., Karunasekara Y., Soboleva T. A., Sharwood R., Whitney S., and, Board P. G., (2005) Using deubiquitylating enzymes as research tools. Methods Enzymol. 398, 540-554.
3. Bertini I., Gonnelli L., Luchinat C., Mao J., and, Nesi A., (2011) A new structural model of Aβ40 fibrils. J. Am. Chem. Soc., 133, 16013-16022.
4. Brody D. L., Magnoni S., Schwetye K. E., Spinner M. L., Esparza T. J., Stocchetti N., Zipfel G. J., and, Holtzman D. M., (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224.
5. Budil D. E., Lee S., Saxena S., and, Freed J. H., (1996) Nonlinear-least-squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. J. Magn. Reson. Ser. A 120, 155-189.
6. Columbus L., Kálai T., Jeko J., Hideg K., and, Hubbell W. L., (2001) Molecular motion of spin labeled side chains in α-helices: analysis by variation of side chain structure. Biochemistry 40, 3828-3846.
7. Frost D., Gorman P. M., Yip C. M., and, Chakrabartty A., (2003) Co-incorporation of Aβ40 and Aβ42 to form mixed pre-fibrillar aggregates. Eur. J. Biochem. 270, 654-663.
8. Gravina S. A., Ho L. B., Eckman C. B., Long K. E., Otvos L., Younkin L. H., Suzuki N., and, Younkin S. G., (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270, 7013-7016.
9. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and, Ihara Y., (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53.
10. Iwatsubo T., Mann D. M. A., Odaka A., Suzuki N., and, Ihara Y., (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37, 294-299.
11. Jan A., Gokce O., Luthi-Carter R., and, Lashuel H. A., (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283, 28176-28189.
12. Kim J., Onstead L., Randle S., Price R., Smithson L., Zwizinski C., Dickson D. W., Golde T., and, McGowan E., (2007) Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633.
13. Kodali R., Williams A. D., Chemuru S., and, Wetzel R., (2010) Aβ(1-40) forms five distinct amyloid structures whose β-sheet contents and fibril stabilities are correlated. J. Mol. Biol. 401, 503-517.
14. Kumar-Singh S., Theuns J., Van Broeck B., Pirici D., Vennekens K., Corsmit E., Cruts M., Dermaut B., Wang R., and, Van Broeckhoven C., (2006) Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Hum. Mutat. 27, 686-695.
15. Kuperstein I., Broersen K., Benilova I., et al,. (2010) Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J. 29, 3408-3420.
16. Lührs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Doeli H., Schubert D., and, Riek R., (2005) 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl Acad. Sci. USA 102, 17342-17347.
17. Mak K., Yang F. S., Vinters H. V., Frautschy S. A., and, Cole G. M., (1994) Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res. 667, 138-142.
18. Margittai M., and, Langen R., (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41, 265-297.
19. McGowan E., Pickford F., Kim J., et al,. (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199.
20. Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K., and, Iqbal K., (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 41-52.
21. Ngo S., and, Guo Z., (2011) Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease. Biochem. Biophys. Res. Commun. 414, 512-516.
22. Olofsson A., Sauer-Eriksson A. E., and, Ohman A., (2006) The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281, 477-483.
23. Pauwels K., Williams T. L., Morris K. L., et al,. (2012) The structural basis for increased toxicity of pathological Aβ42:Aβ40 ratios in Alzheimer's disease. J. Biol. Chem. 287, 5650-5660.
24. Petkova A. T., Leapman R. D., Guo Z. H., Yau W. M., Mattson M. P., and, Tycko R., (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265.
25. Schneider D. J., and, Freed J. H., (1989) Calculating slow motional magnetic resonance specta, in Spin Labeling: Theory and Applications, (, Berliner L. J., and, Reuben J., eds), pp. 1-76. Plenum Press, New York.
26. Shahnawaz M., Thapa A., and, Park I. S., (2007) Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides. Biochem. Biophys. Res. Commun. 359, 801-805.
27. Snyder S. W., Ladror U. S., Wade W. S., Wang G. T., Barrett L. W., Matayoshi E. D., Huffaker H. J., Krafft G. A., and, Holzman T. F., (1994) Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
28. Török M., Milton S., Kayed R., Wu P., McIntire T., Glabe C. G., and, Langen R., (2002) Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 40810-40815.
29. Tycko R., (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 39, 1-55.
30. Yan Y., and, Wang C., (2007) Aβ40 protects non-toxic Aβ42 monomer from aggregation. J. Mol. Biol. 369, 909-916.
31. Yoshiike Y., Chui D. H., Akagi T., Tanaka N., and, Takashima A., (2003) Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J. Biol. Chem. 278, 23648-23655.